EORTC publishes its 2024 Annual Report: Driving progress in cancer treatment, together

The European Organisation for Research and Treatment of Cancer (EORTC) is pleased to announce the publication of its 2024 Annual Report, now available online here.

The 2024 report highlights EORTC’s continued commitment to fostering innovative, independent cancer research across Europe and beyond. It showcases key scientific achievements, collaborative milestones, and progress in clinical trials that aim to improve survival and quality of life for patients with cancer.

“In 2024, EORTC reaffirmed its central role in academic oncology research by expanding international partnerships, launching pivotal studies, and leveraging real-world data to address unmet patient needs,” said Dr. Denis Lacombe, EORTC Chief Executive Officer. “While outlining our vision for the future, this report reflects the continued dedication of our scientific community and our mission to improve patient care through rigorous, patient-centred research,” added Prof. Winette van der Graaf, EORTC President.

The report features:

• EORTC’s new Scientific Strategy and its Task Forces;
• Highlights from major research programmes and disease-oriented groups;
• Updates on clinical trials and data-driven initiatives;
• Strategic partnerships and stakeholder engagement;
• Financial and organisational developments.

EORTC thanks its members, partners, patients, and funders for their continued support and collaboration throughout 2024. As we look ahead, our focus remains on fostering impactful research and accelerating the translation of evidence into practice.

Explore the full EORTC Annual Report 2024 to learn more.